4-(1,3,4-Oxadiazol-2-yl)benzoic acid

Catalog No. :
ACBHPA971
CAS No. :
59663-66-0
Molecular Formula :
C9H6N2O3
Molecular Weight :
190.16

IUPAC Name:4-(1,3,4-oxadiazol-2-yl)benzoic acid

4-(1,3,4-Oxadiazol-2-yl)benzoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$127.00Login to see priceInquiryInquiry
5g95%$371.00Login to see priceInquiryInquiry
10g95%$566.00Login to see priceInquiryInquiry
25g95%$956.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(1,3,4-Oxadiazol-2-yl)benzoic acid
IUPAC Name4-(1,3,4-oxadiazol-2-yl)benzoic acid
MDL No.MFCD07352166
Molecular FormulaC9H6N2O3
Molecular Weight190.16
SMILESO=C(O)C1=CC=C(C2=NN=CO2)C=C1
InChI KeyIZTWSORAYAOGDE-UHFFFAOYSA-N
Synonym4-(1,3,4-oxadiazol-2-yl)benzoic Acid | 59663-66-0 | 4-[1,3,4]Oxadiazol-2-yl-benzoic acid | 4-(1,3,4-Oxadiazol-2-yl)benzoicacid | SCHEMBL69432 | DTXSID60427895 | IZTWSORAYAOGDE-UHFFFAOYSA-N | HMS1784O13 | MFCD07352166 | AKOS000118400 | AM807337 | BS-13918 | CS-0454054 | FT-0747152 |
CAS No.59663-66-0
PubChem CID7131055

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACBHPA971 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXHOT631 route compound structure diagram
    ACXHOT63146206-74-0 In Stock
  4. Then
  5. ACBHPA971 route product structure diagram
    ACBHPA97159663-66-0
Inquiry

2. ACBHPA971 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBHPA971 route product structure diagram
    ACBHPA97159663-66-0
Inquiry

Comments (0)